Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDEnveric Biosciences Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/14/2026 | Q2 2026 | N/A | -$0.76 | N/A | N/A | $0 |
| 05/15/2026 | Q1 2026 | N/A | -$1.08 | N/A | N/A | $0 |
| 03/27/2026 | Q4 2025 | -$55.80 | -$3.81 | 51.99 | N/A | $0 |
| 11/14/2025 | Q3 2025 | -$63.00 | -$10.81 | 52.19 | N/A | $0 |
| 08/14/2025 | Q2 2025 | N/A | -$11.64 | N/A | N/A | $0 |
| 05/14/2025 | Q1 2025 | N/A | -$14,584.44 | N/A | N/A | $0 |
| 03/28/2025 | Q4 2024 | N/A | -$69.84 | N/A | N/A | $0 |
| 11/14/2024 | Q3 2024 | -$0.52 | -$43.08 | -42.56 | N/A | $0 |
| 08/12/2024 | Q2 2024 | N/A | -$16.08 | N/A | N/A | $0 |
| 05/14/2024 | Q1 2024 | -$0.77 | -$21.00 | -20.23 | N/A | $0 |
| 03/25/2024 | Q4 2023 | -$1.55 | -$33.51 | -31.96 | N/A | $0 |
| 11/13/2023 | Q3 2023 | -$347.37 | -$27.53 | 319.84 | N/A | $0 |
| 08/11/2023 | Q2 2023 | N/A | -$62.42 | N/A | N/A | $0 |
| 05/15/2023 | Q1 2023 | -$33.45 | -$46.82 | -13.37 | N/A | $0 |
| 06/08/2023 | Q4 2022 | N/A | -$85.84 | N/A | N/A | $0 |
| 11/14/2022 | Q3 2022 | N/A | -$25.38 | N/A | N/A | $0 |
| 08/12/2022 | Q2 2022 | -$3.75 | -$10.08 | -6.33 | N/A | $0 |
| 05/13/2022 | Q1 2022 | -$4.00 | -$60.12 | -56.12 | N/A | $0 |
| 03/31/2022 | Q4 2021 | -$8.00 | -$1,091.64 | -1083.64 | N/A | $0 |
| 11/12/2021 | Q3 2021 | N/A | -$70.92 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Enveric Biosciences Inc Earnings: FAQ's
In the previous quarter, Enveric Biosciences Inc (:ENVB) reported $0.85 earnings per share (EPS) to beat the analysts' consensus estimate of $-55.8 by $56.65.
The conference call for Enveric Biosciences Inc's latest earnings report can be listened to online.
The conference call transcript for Enveric Biosciences Inc's latest earnings report can be read online.
Enveric Biosciences Inc (:ENVB) has a recorded net income of $-12,131,472.Enveric Biosciences Inc has generated $-36.24 earnings per share over the last four quarters.
Enveric Biosciences Inc (:ENVB) has a price-to-earnings ratio of -0.09 and price/earnings-to-growth ratio is -0.